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Reduction in Kv Current Enhances the Temporal Dispersion of the
Action Potential in Diabetic Myocytes: Insights From a Novel
Repolarization Algorithm
Marianna Meo, PhD;* Olivier Meste, PhD;* Sergio Signore, PhD; Andrea Sorrentino, MS; Antonio Cannata, MD; Yu Zhou, MS;
Alex Matsuda, BS; Marco Luciani, MD; Ramaswamy Kannappan, PhD; Polina Goichberg, PhD; Annarosa Leri, MD; Piero Anversa, MD;
Marcello Rota, PhD
Background-—Diabetes is associated with prolongation of the QT interval of the electrocardiogram and enhanced dispersion of
ventricular repolarization, factors that, together with atherosclerosis and myocardial ischemia, may promote the occurrence of
electrical disorders. Thus, we tested the possibility that alterations in transmembrane ionic currents reduce the repolarization
reserve of myocytes, leading to action potential (AP) prolongation and enhanced beat-to-beat variability of repolarization.
Methods and Results-—Diabetes was induced in mice with streptozotocin (STZ), and effects of hyperglycemia on electrical
properties of whole heart and myocytes were studied with respect to an untreated control group (Ctrl) using electrocardiographic
recordings in vivo, ex vivo perfused hearts, and single-cell patch-clamp analysis. Additionally, a newly developed algorithm was
introduced to obtain detailed information of the impact of high glucose on AP profile. Compared to Ctrl, hyperglycemia in STZ-
treated animals was coupled with prolongation of the QT interval, enhanced temporal dispersion of electrical recovery, and
susceptibility to ventricular arrhythmias, defects observed, in part, in the Akita mutant mouse model of type I diabetes. AP was
prolonged and beat-to-beat variability of repolarization was enhanced in diabetic myocytes, with respect to Ctrl cells. Density of Kv
K+ and L-type Ca2+ currents were decreased in STZ myocytes, in comparison to cells from normoglycemic mice. Pharmacological
reduction of Kv currents in Ctrl cells lengthened AP duration and increased temporal dispersion of repolarization, reiterating
features identified in diabetic myocytes.
Conclusions-—Reductions in the repolarizing K+ currents may contribute to electrical disturbances of the diabetic heart. ( J Am
Heart Assoc. 2016;5:e003078 doi: 10.1161/JAHA.115.003078)
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D iabetes is a major risk factor for cardiovasculardiseases, including ventricular arrhythmia and sudden
death.1–3 Prolongation of the QT interval and increased
dispersion of repolarization have been observed in the
diabetic population,4–10 and these variables, together with
intervening comorbidities,11 represent critical substrates for
the occurrence of electrical disturbances.4,12–17 But whether
alterations at the cellular level contribute to protracted
electrical recovery and repolarization variability with diabetes
remain to be determined.
Prolongation of the action potential (AP) in cardiomyocytes
is typically observed in the hypertrophied and failing heart,18
with major consequences on intracellular Ca2+ homeostasis
and contractile force developed by the myocardium.18–20
Moreover, the protracted AP predisposes myocytes to the
occurrence of early afterdepolarizations, which may trigger
extrasystoles and tachyarrhythmias and/or aggravate the
dispersion of repolarization of the myocardium in the presence
of local nonpropagating responses.21 Similarly, beat-to-beat
variability of repolarization, which is observed at the single-cell
level and in thewhole heart,22,23 has detrimental consequences
onmyocardial electrical stability by facilitating the development
of reentrant arrhythmias.15,16,21,24 Importantly, these defects
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may be equally operative in the diabetic heart, representing
important variables in the propensity to develop ventricular
arrhythmias and sudden death in the presence of this disease.
In the present study, we have evaluated the properties and
temporal dispersion of cardiac electrical recovery in diabetic
mice and their propensity to develop arrhythmias together
with the implementation of a novel analysis of AP to establish
the duration and degree of variability of myocyte repolariza-
tion. Kv and L-type Ca2+ current densities were reduced in
diabetic cells, and Kv current inhibition in control myocytes
prolonged the AP profile and enhances its variability. These
results suggest that defective repolarizing K+ current con-
tributes to electrical disturbances of the diabetic heart.
Materials and Methods
In Vivo Studies
Female C57Bl/6 mice (n=170) or male C57BL/6-Ins2Akita/J
(Akita; #003548; n=8; The Jackson Laboratory, Bar Harbor,
ME) and male wild-type (WT; n=7) mice were studied in accord
with the Guide for Care and Use of Laboratory Animals;
experiments were approved by the local animal care commit-
tee. When needed, isoflurane (1–1.5%, inhalation) was
employed as a methodology of anesthesia.
To induce hyperglycemia, female C57Bl/6 mice at 3 to
6 months of age (n=112) were treated with streptozotocin
(STZ; Sigma-Aldrich, St. Louis, MO) for 4 to 6 consecutive
days (100 mg/kg body weight per day, intraperitoneally).
Female na€ıve C57Bl/6 mice at 3 to 6 months of age (n=58)
served as control animals. STZ was dissolved in 0.9% saline
solution containing 20 mmol/L of sodium citrate tribasic
dihydrate (Sigma-Aldrich). Final STZ concentration was 5 mg/
L. Glucose levels were assessed using a TRUEtrack meter
(Home Diagnostics, Inc., Fort Lauderdale, FL) and test strips.
Animals with blood glucose level >300 mg/dL were included
in the study. Glucose levels and their changes over time in
STZ-treated and Akita mice are reported in Figure S1.
Echocardiography was performed in mice using a
VisualSonics Vevo 2100 System equipped with a MS550D
high-frequency (22–55 MHz) linear transducer (VisualSonics
Inc., Toronto, Ontario, Canada). Short-axis views of the left
ventricle (LV) were obtained in conscious mice20,25 to
compute LV volume and ejection fraction (EF) by the Teichholz
formula. Diastolic function was assessed using pulsed-wave
Doppler imaging of the transmitral filling pattern in the apical
4-chamber view of the heart in mice anesthetized with
isoflurane. Early transmitral filling wave (E-wave) and late
filling wave attributable to atrial contraction (A-wave) were
obtained. Deceleration time of the E-wave was determined by
measuring the time needed for the down-slope of the peak of
the E-wave to reach baseline.20
Electrocardiograms (ECGs) were recorded under isoflurane
anesthesia by inserting needle electrodes subcutaneously into
mouse limbs (lead II). Electrical signals were amplified (Animal
Bio Amp; ADInstruments, Houston, TX), digitized using a 4-kHz
A/D converter (MPVS-400; Millar Instruments, Houston, TX)
and recorded using LabChart software (ADInstruments), with
low- and high-pass filtering at 100 and 3 Hz, respectively.
Surface ECG intervals were measured using LabChart (version
7 or 8; ADInstruments).20 To reduce electrical noise and
motion artifacts, 50 consecutive beats were averaged by the
software and employed to calculate heart rate and electro-
cardiographic parameters. PR interval, QRS duration, and QT
interval were measured by determining the earliest onset and
latest offset of atrial and ventricular deflections from the
averaged cycles.20 Rate-corrected QT interval (QTc) was
calculated using the Bazett formula (QTc=QT/√RR). This
analysis was extended to a total of 500 beats to determine
average interval durations and variability.
To record ECGs in freely roaming, unanesthetized animals,
telemetric biopotential transmitters (ETA-F10; Data Science
International, New Brighton, MN) were implanted subcuta-
neously in mice anesthetized with isoflurane (1–1.5%, inhala-
tion).20 Leads were secured subcutaneously corresponding to
position II. Subsequently, signals were transmitted from
implants to RPC-1 receivers and Data Exchange Matrix (Data
Science International) and stored in a computer. The
telemetric ECG was analyzed during normal activity and for
90 minutes after pharmacological treatments. All recordings
were digitized at 2 kHz and analyzed offline with Ponemah
software (version 5.10).
LV hemodynamics and pressure-volume (PV) loops were
obtained in anesthetized mice (isoflurane, 1.5%) in the closed-
chest preparation with a MPVS-400 system for small animals
(Millar Instruments) equipped with a PVR-1045 catheter.20,25
The mouse was intubated and ventilated (MiniVent Type 845;
Hugo Sachs Elektronik-Harvard Apparatus, GmbH, March,
Germany) with isoflurane anesthesia; the right carotid artery
was then exposed and the pressure transducer was inserted
and advanced in the LV cavity. Data were acquired with
Chart 5 or LabChart8 (ADInstruments) software.
For combined autonomic blockade, atropine (0.5 mg/kg
body weight, intraperitoneally; Hospira , Lake Forest, IL) plus
propranolol (1 mg/kg body weight, intraperitoneally; Fluka
Chemie GmbH, Buchs, Switzerland) were administered to
animals.20,26 Compounds were dissolved in USP saline
solution.
To establish the propensity to develop arrhythmias, mice
were treated with caffeine (120 mg/kg body weight, intraperi-
toneally; Sigma-Aldrich) and epinephrine (2 mg/kg body
weight, intraperitoneally; Sigma-Aldrich).27–29 Compounds
were dissolved in USP saline solution. Occurrence of
arrhythmia was monitored in anesthetized control (Ctrl) and
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STZ mice for 19.65.3 (n=7) and 19.63.4 minutes (n=7)
after administration of drugs, respectively. By telemetry,
occurrence of arrhythmias in conscious mice was monitored
for 90 minutes after treatment with caffeine and epinephrine.
Ex Vivo Properties of the Mouse Heart
To assess ex vivo electrical properties, hearts were perfused
through the aorta in a Langendorff apparatus (Radnoti LLC,
Monrovia, CA) at a constant pressure of 80 mm Hg with
Krebs–Henseleit buffer (KHB; Sigma-Aldrich), containing (in
mmol/L): 118 NaCl, 4.7 KCl, 11 glucose, 1.2 MgSO4, 1.2
KH2PO4, 1.8 CaCl2 and 25 NaHCO3, gassed with 95% O2 and
5% CO2 (pH 7.4) at 37°C.
19,20 Temperature was maintained by
immersing the heart in a water-heated glassware reservoir
(Radnoti LLC), containing preheated KHB. Hearts were
stimulated at 125-ms basic cycle length with a 2-ms square
pulse at 1.5-fold its threshold level (4-channel stimulator, BMS
414; Crescent Electronics, Sandy, UT), using a minicoaxial
electrode (Harvard Apparatus, Cambridge, MA). Monophasic
action potentials (MAPs) were recorded using a micro-MAP-
Tip electrode (Harvard Apparatus) initially positioned on the
apical and then on the basal region of the epicardium of the
LV free wall. Subsequently, the LV was opened and the MAP
electrode was positioned on the endocardial aspect of the LV
free wall. MAP signal was amplified (Animal Bio Amp;
ADInstruments), digitized by a 4-kHz A/D converter (Power
Lab 8/30; ADInstruments), and recorded with LabChart soft-
ware, with low- and high-pass filtering at 1 kHz and 0.3 Hz,
respectively. Data were analyzed with LabChart software.
Myocyte Isolation and Patch-Clamp Studies
With the animals under deep anesthesia (isoflurane), hearts
were excised and LV myocytes were enzymatically dissociated
as reported previously.19,20,25,30 Briefly, the heart was
connected to a plastic cannula for retrograde perfusion
through the aorta in a Langendorff system (Radnoti LLC) at
37°C at constant flow. Perfusate consisted of a Ca2+-free
solution gassed with 85% O2 and 15% N2. After 5 minutes,
0.1 mmol/L of CaCl2, 274 units/mL of collagenase (type 2;
Worthington Biochemical Corporation, Lakewood, NJ), and
0.57 units/mL of protease (Type XIV; Sigma-Aldrich) were
added to the solution, which contained (in mmol/L): NaCl
126, KCl 4.4, MgCl2 5, HEPES 5, glucose 22, taurine 20,
creatine 5, Na pyruvate 5, and NaH2PO4 5 (pH 7.4). At
completion of digestion, atria and right ventricle were
dissected and free wall of the LV was cut in small pieces,
and these fragments were shaken in resuspension solution
and filtered using a 200-lm nylon mesh (Spectrum Labora-
tories Inc, Piscataway, NJ). For electrophysiological studies,
only rod-shaped myocytes exhibiting cross-striations and
showing no spontaneous contractions or contractures were
selected; cells were used within 8 hours after enzymatic
digestion.
Isolated LV myocytes were placed in a bath on the stage of
an IX51, IX53, or IX71 (Olympus, Tokyo, Japan) microscopes
for patch-clamp measurements.19,25,30,31 Experiments were
conducted at 37°C. Data were acquired by means of the
whole-cell patch-clamp technique in voltage- and current-
clamp modes using Multiclamp 700A, 700B, and Axoclamp
900A amplifiers (Molecular Devices, Sunnyvale, CA). Electrical
signals were digitized using 250-kHz 16-bit resolution A/D
converters (Digidata 1322, 1440A, and 1550; Molecular
Devices) and recorded using pCLAMP 9.0 and 10 software
(Molecular Devices) with low-pass filtering at 2 kHz. Mem-
brane capacitance (Cm) was measured in voltage-clamp mode
using a 5-mV voltage step and pCLAMP software algorithm;
this parameter was employed to normalize transmembrane
currents.19,20,25,30 Pipettes were pulled by means of a vertical
(PB-7; Narishige International Inc., East Meadow, NY), or
horizontal (P-1000; Sutter Instrument Co, Novato, CA) glass
microelectrode pullers.
For AP measurements, current-clamp mode was
employed.19,20,30,31 Cells were stimulated with current pulses
1.5 times threshold. Myocytes were bathed with Tyrode
solution containing (in mmol/L): NaCl 140, KCl 5.4, MgCl2 1,
HEPES 5, glucose 5.5, and CaCl2 1 (pH 7.4, adjusted with
NaOH). The composition of the pipette solution was (in
mmol/L): NaCl 10, KCl 113, MgCl2 0.5, K2-ATP 5, glucose
5.5, HEPES 10, EGTA 10, and CaCl2 1 (pH 7.2 with KOH). To
test the effects of inhibition of Kv currents, APs were
continuously recorded for the same cells before and after
exposure to 4-aminopyridine (4-AP; 0.1 mmol/L).30,32–35 At
this concentration level, 4-AP has been previously reported
to abolish the large, slowly inactivating phase of the Kv-
based IK,slow
32,34,35 leading to prolongation of AP.33 To test
the acute effects of high glucose, APs were continuously
recorded for the same cells before and after exposure to a
Tyrode solution containing 20 mmol/L of glucose. Experi-
ments testing the effects of high glucose were performed at
room temperature.
Voltage-gated outward K+ Kv currents were assessed in
voltage-clamp mode with Tyrode solution containing
0.3 mmol/L of CdCl2 to block L-type Ca
2+ current.30
Current-voltage (I-V) relations were determined applying
depolarizing steps in the range from 50 to +80 mV, in 10-
mV increments, 500 ms in duration. Test steps were
preceded by a prestep to 30 mV, 20 ms in duration, from
holding potential (Vh) of 70 mV. Amplitude of Kv currents
was measured as the difference between the peak outward
current at the beginning of the test step and Iss, the current at
the end of the 500-ms step.30 Currents were normalized
by Cm.
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L-type Ca2+ current (ICaL) was measured in voltage-clamp
mode.20,25,30 Myocytes were bathed with a modified Na+-K+–
free Tyrode solution of the following composition (in mmol/L):
N-methyl-D-glucamine (NMDG) 140, CsCl 4, MgCl2 1, HEPES
5, glucose 5.5, CaCl2 1, and 4-AP 2 (pH 7.4 with CsOH).
Composition of the pipette solution was (in mmol/L): NMDG
10, CsCl 113, MgCl2 0.5, Tris-ATP 5, glucose 5.5, HEPES 10,
EGTA 5, and TEA-Cl 20 (pH 7.2 with CsOH). ICaL current-
voltage (I-V) relation and activation properties were deter-
mined applying depolarizing steps 300 ms in duration from Vh
70 mV in 10-mV increments. ICaL amplitude was measured
as the current difference between the peak inward current at
the beginning of the step and the current at the end of the
300-ms pulse. ICaL was normalized by Cm.
Equilibrium potential for Ca+ was defined by the intercept
of the I-V relation to the zero-current axis. A linear fitting of
the positive potential portion of the I-V relation was employed
for this determination.20 At each potential tested (Vm), Ca
2+
conductance (g) was calculated as
g ¼ ICaL=ðVm  ECaÞ
where ICaL is the amplitude of the L-type Ca
2+ current at Vm.
Values of normalized Ca2+ conductance (G=g/gmax) were
plotted to obtain activation curves; half maximal activation
potential (V1/2G) and slope of the activation curve (kG) were
derived by fitting the data with the Boltzmann equation:
G ¼ 1=1þ exp½ðV1=2G  VmÞ=kG
A 2-pulse protocol was utilized to assess the voltage
dependence of steady-state inactivation of ICaL. Prepulses
were introduced to depolarize the cell to different membrane
voltages starting from 80 mV for 300 ms, in 10-mV
increments. Each prepulse was followed by a single 300-ms
test pulse, which depolarized the cell to 0 mV. Values of
normalized Ca2+ conductance (G=g/gmax) were plotted with
Vm relative to the preconditioning steps to determine steady-
state inactivation curves, fitted with a Boltzmann equation, as
indicated above.
Inactivation time course of ICaL was studied with a 1000-
ms depolarizing pulse at 0 mV.30 Traces were fitted between
the inward peak and to 500 ms from the beginning of the
pulse to 0 mV with a biexponential function20,31:
IðtÞ ¼ Af  expðt=sfÞ þ As  expðt=ssÞ þ C
where Af and As are, respectively, the fraction of the fast and
slow inactivating components, sf and ss are the time
constants of the fast and slow inactivating component, and
C is the offset constant.
ICaL reactivation was studied using a protocol consisting of
4 preconditioning pulses at 1-Hz depolarizing cells from Vh
70 to 0 mV for 50 ms. The test pulse was elicited with
progressive delay, ranging from 50 to 500 ms, in increaments
of 50 ms. With each test pulse, ICaL was activated by
depolarizing cells from Vh 70 to 0 mV for 200 ms. For each
interpulse duration (t), ICaL reactivation was calculated by
dividing the amplitude of the current measured during the test
pulse (I(t)) by the maximal amplitude of the current measured
with prolonged interpulse duration (Imax). Values of ICa
reactivation were plotted to obtain reactivation curves and
fitted with a monoexponential function:
IðtÞ=IðmaxÞ ¼ 1 expðt=sÞ:
Quantification of Temporal Variability
Variability of electrocardiographic parameters was computed
using SD and RSD (RSD=(SD/mean)9100)22,36,37 on 10
consecutive series of 50 beats that were averaged to reduce
electrical noise and motion artifacts. To minimize the
confounding impact of severe functional defects and struc-
tural remodeling of the myocardium, the analysis of temporal
variability was initially restricted to STZ-treated animals up to
2 months after onset of diabetes. Similarly, 7-month-old Akita
mice were studied because EF was preserved at this age.
Variability of AP repolarization was computed using SD,
RSD, and short-term variability (STV)22,36,37 on 70 consecutive
waveforms of the 100 APs obtained from each cell in the
control and diabetic groups. STV was calculated using the
following formula:





where APD is the duration of the duration of the AP at a given
repolarization level. For experiments in which myocytes were
exposed to 4-AP to inhibit Kv currents, 10 consecutive
waveforms at steady state after drug application were used
for the analysis of variability.
Newly Developed Repolarization Analysis
A newly developed algorithm for assessment of the
repolarization phase was employed in this study. This
method, based on fitting of the AP decay, was introduced
to obtain detailed information on the repolarization proper-
ties of myocytes. By this strategy, the attempt was made to
identify recovery abnormalities and temporal dispersion
throughout the entire repolarization phase of the AP, with
the exception of the final portion, from 95% of repolariza-
tion to return to resting membrane potential. A signal-
processing method previously used for ECG recordings38
was adapted for analysis of APs. Briefly, Axon binary files
containing a sequence of APs in the form of sequential
sweeps were converted into text files. Subsequently, data
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were imported in Matlab (MathWorks, Inc., Natick, MA)
software as matrices with size b x S, where b is the
number of sequential sweeps (APs) and S is the number of
samples collected during each sweep. Each repolarization
phase of the AP was modeled using the following steps: (1)
segmentation of the repolarization phase of the AP and
normalization of the AP amplitude in the interval [0–1]; (2)
fitting of repolarization intervals based on least square approx-
imation, subjected to monotonically decreasing behavior
constraints38; and (3) interpolation of the reciprocal functions
Figure 1. Hyperglycemia is accompanied by a progressive deterioration of cardiac function. A,
Echocardiographic parameters in female streptozotocin (STZ) mice (STZ) at 2 weeks (2 weeks,
n=11), 1 month (1 month; n=20), and 2 months (2 months; n=14) after onset of hyperglycemia
and in control (Ctrl) mice (2 weeks, n=11; 1 month, n=20; 2 months, n=10). Quantitative data are
shown as median and interquartile ranges (IQRs). *P<0.05 vs corresponding time point in Ctrl. B,
Transmitral flow Doppler echocardiograms from Ctrl and STZ female mice. E, Early passive filling wave; A,
active filling wave. C, Quantitative data for Ctrl (2 weeks, n=11; 1 month, n=8) and STZ female mice at
2 weeks (2 weeks; n=10) and 1 month (1 month; n=10) after onset of hyperglycemia. Results are
shown as median and IQRs. *P<0.05 vs corresponding time point in Ctrl. D, Hemodynamic and volumetric
parameters obtained by PV catheterization in Ctrl (n=13) and STZ female mice 60 to 100 days (mean,
83.73.1 days) after onset of hyperglycemia (n=13). Data are shown as median and IQR. *P<0.05 vs Ctrl.
bpm indicates beats per minute; LV, left ventricular; P, pressure.
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Figure 2. Hyperglycemia leads to protracted electrical recovery of the heart in vivo. A, Electrocardiograms obtained in control (Ctrl)
and streptozotocin (STZ)-treated (STZ) female mice. B, Electrocardiographic parameters in Ctrl (n=23) and STZ (n=22) female mice at
14 to 18 days (2 weeks) after onset of hyperglycemia are shown as median and interquartile ranges (IQRs). *P<0.05 vs Ctrl. C,
Electrocardiographic parameters in Ctrl (n=11) and STZ (n=27) female mice at 31 to 38 days (1 month) after onset of hyperglycemic
condition are shown as median and IQRs. *P<0.05 vs Ctrl. D, ECGs obtained in wild-type (WT) and male Akita mice. E,
Electrocardiographic parameters in wild-type (WT, n=6) and male Akita (n=7) mice at 7 months of age are shown as median and IQRs.
*P<0.05 vs WT. wks indicates weeks.
DOI: 10.1161/JAHA.115.003078 Journal of the American Heart Association 6





















of the obtained fitting over a fixed range of the AP repolarization.
Details are reported in Data S1.
For each myocyte, the obtained values of duration of
repolarization segments for sequential APs computed with the
algorithm were then employed to calculated average AP
profile and degree of beat-to-beat variability. Parameters
obtained in each cells were then used to compute average AP
profile for control myocytes, STZ-myocytes and for cells
before and after exposure to 4-AP or high glucose. Similarly,
fold change and statistical comparison between 2 experi-
mental groups were calculated. Repolarization properties
were graphically visualized using Prism software, with repo-
larization levels on the y axis and repolarization time on the x
axis.
Data Analysis
Data are presented as median and interquartile ranges (IQRs)
or meanSEM. Linear regressions and Pearson’s correlation
coefficient were calculated with Prism software. Statistical
analysis was performed using SigmaPlot 11.0. Data were
initially tested for normality (Shapiro–Wilk) and equal
variance for assignment to parametric or nonparametric
analysis. Parametric tests included Student t test or paired
t test for nonpaired or paired comparison between 2 sets
of data, respectively. When normality or equal variance
were not met, nonparametric analysis was performed using
the Mann–Whitney rank-sum test or the Wilcoxon signed-
rank test for nonpaired or paired comparison between 2
sets of data, respectively. For categorical data analysis,
Fisher’s exact test was used.20 P<0.05 was considered
significant.
Results
Hyperglycemia and Diabetic Cardiomyopathy
To define the effects of elevated glucose levels on cardiac
functions, Ctrl and STZ-injected diabetic (STZ) female mice
were monitored by echocardiography at 2 weeks,
Figure 3. Hyperglycemia enhances temporal dispersion of electrical recovery. A and B, Variability of the electrical recovery evaluated by SD
and RSD in control (Ctrl) and streptozotocin (STZ) female mice at 2 weeks (A, same animals as in Figure 2B) and 1 month (B, same animals
as in Figure 2C) after onset of the hyperglycemia is shown as median and interquartile ranges (IQRs). *P<0.05 vs Ctrl. C, Variability of the
electrical recovery evaluated by SD and RSD in WT and Akita male mice (same animals as in Figure 2E) is shown as median and IQRs. *P<0.05
vs WT. D, Electrocardiographic parameters and variability of repolarization assessed after complete autonomic block in Ctrl (n=10) and STZ
(n=6) female mice at 168 to 183 days after onset of hyperglycemic conditions are shown as median and IQRs. *P<0.05 vs Ctrl. E,
Electrocardiographic parameters and variability of repolarization assessed after complete autonomic block in WT (n=6) and Akita (n=7) male
mice at 9 months of age are shown as median and IQRs. *P<0.05 vs WT. bpm indicates beats per minute.
DOI: 10.1161/JAHA.115.003078 Journal of the American Heart Association 7





















1 month, and 2 months from onset of the hyperglycemic
state. EF was initially preserved in STZ mice, but decreased by
12% at 2 months, together with an increase in diastolic LV
volume (Figure 1A). By transmitral flow Doppler echocardio-
graphy, passive LV filling (E wave) was reduced, whereas
deceleration time was prolonged in STZ mice, at 2 weeks and
1 month, with respect to Ctrl (Figure 1B and 1C). Thus,
impairment of diastolic function with diabetes precedes the
reduction in EF. Additionally, by hemodynamics and PV
measurements in the closed-chest preparation at 2 to
3 months after onset of hyperglycemia, developed pressure
was comparable in STZ and Ctrl mice. However, +dP/dt was
attenuated and the time constant of pressure decay (tau) was
prolonged in the STZ group. Despite these alterations, stroke
volume and cardiac output were preserved in diabetic animals
(Figure 1D).
To establish whether hyperglycemia affected electrical
activation and recovery of the myocardium before changes in
EF become apparent, surface ECGs were acquired. In diabetic
hearts at 2 weeks, atrioventricular conduction (PR interval)
and ventricular activation (QRS interval) were similar to Ctrl. In
contrast, indices of electrical recovery (QT interval and heart-
rate–adjusted QTc) were prolonged in diabetic mice by 16.9%
and 14.4%, respectively (Figure 2A and 2B). These alterations
were maintained at the later time point (1 month;
Figure 2C).
To corroborate findings observed in mice with diabetes
induced by STZ administration and to reduce the potential
confounding off-target effects of pharmacological treatment,
we studied male Akita mice, a rodent model of naturally
occurring diabetes type I attributable to a spontaneous
mutation of the insulin 2 gene that causes misfolding of the
Figure 3. Continued
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insulin protein and hyperglycemia (see Figure S1).39 With
respect to age- and sex-matched wild-type (WT) animals, Akita
mice displayed prolonged QT interval and QTc (Figure 2D and
2E), whereas cardiac function, evaluated by echocardiogra-
phy, was relatively preserved (Figure S2). Thus, hyperglycemia
is characterized early by delays in electrical recovery of the
myocardium and diastolic dysfunction, whereas systolic
defects occur later in the process.
Hyperglycemia and Electrical Disturbances
Clinically, there are several inherited and acquired conditions,
including diabetes,4,5,9,10,12,13 that are characterized by
prolongation of the QT interval, a factor that enhances the
incidence of ventricular arrhythmia and sudden cardiac
death.14 Moreover, increased dispersion of ventricular repo-
larization occurs in diabetic patients5–8,10 with an important
implication on propensity to develop electrical distur-
bances.4,13,15,16 To test the possibility that prolonged electri-
cal recovery with hyperglycemia was associated with
increased repolarization variability and rhythm disturbances,
the degree of temporal dispersion of myocardial repolarization
and susceptibility to develop arrhythmias were quantified. In
both STZ-treated and Akita mice, hyperglycemia was coupled
with an increase in QT and QTc variability, evaluated by SD
and RSD22,36,37 (Figure 3A through 3C). Additionally, because
diabetes is associated with autonomic imbalance,40 an
important determinant of QT variability,41 ECGs were obtained
in control and chronic diabetic mice after complete autonomic
blockade with atropine and propranolol.26 In spite of this
intervention, QT interval and QTc and respective temporal
variability remained elevated in diabetic animals (Figure 3D
and 3E and Figure S3).
To establish the propensity of diabetic mice to develop
ventricular arrhythmias, ECGs were evaluated in anesthetized
Ctrl and STZ mice before and after administration of caffeine
and epinephrine.27–29 This intervention induced ventricular
tachycardia (VT) in 1 of the 7 Ctrl mice, whereas in the
majority of diabetic animals (6 of 7), it elicited a bidirectional
pattern of ventricular activation (Figure 4A through 4C),
previously identified as bidirectional VT (BVT).28,29,42 BVT
was associated with a reduction in RR interval (Figure 4D)
coupled with enhanced sinus discharge. Occurrence of BVT in
STZ animals after administration of caffeine and epinephrine
was also confirmed in conscious mice by telemetry (Fig-
ure 4E). Collectively, these data indicate that hyperglycemia
leads to prolongation of the electrical recovery, enhances
dispersion of ventricular repolarization, and increases sus-
ceptibility to develop ventricular arrhythmia.
Hyperglycemia and Myocyte Electrical Properties
To determine whether alterations in electrophysiological
properties of cardiomyocytes mirrored the electrical defects
observed in vivo, isolated cell preparations from the LV free
wall of STZ and Ctrl mice were studied by patch-clamp. The
Figure 4. Hyperglycemia enhances the propensity to develop arrhythmias. A and B, Electrocardiographic recordings of sustained bidirectional
ventricular tachycardia (VT) in a streptozotocin (STZ)-treated female mouse after administration of caffeine and epinephrine, under anesthesia.
C, Occurrence of ventricular arrhythmias in control (Ctrl; n=7) and STZ (n=7; 13–24 days after STZ administration) anesthetized female mice.
*P<0.05 vs Ctrl. D, RR interval duration before (normal) and during the appearance of bidirectional VT (bidirectional) in STZ female mice (n=6;
13–24 days after STZ administration). *P<0.05 vs normal. E, Telemetric ECG recording of sustained bidirectional VT in a conscious diabetic
female mouse, 28 days after STZ administration. The mouse was treated with caffeine and epinephrine. After drug administration, bidirectional
VT was observed in 1 of the 2 diabetic female mice implanted with telemetry. Arrhythmia was not observed after treatment in 4 Ctrl female
mice.
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standard analysis of AP characteristics19,30 was comple-
mented with a newly developed algorithm for assessment of
the repolarization phase.
At a 2-Hz stimulation rate, resting membrane potential, AP
amplitude, and dV/dtmax were comparable in control and
diabetic myocytes. In contrast, dV/dtmin was reduced by 63%
whereas the duration of AP at 10%, 30%, 50%, and 70% were
significantly prolonged in diabetic cells (Figure 5A and 5B).
Using the newly developed algorithm, an uninterrupted
prolongation of AP duration was found in diabetic myocytes,
in the range comprised from 0.19%, which corresponds to the
first analyzed data point of the repolarization, to 79.4% of the
repolarization phase (Figure 5C). Prolongation of the AP
varied from 1.2- to 2.8-fold, with respect to Ctrl cells, reaching
a maximum at 23.2% of the repolarization phase. Importantly,
values of duration of repolarization computed with the newly
developed approach were similar to results obtained at
discrete repolarization levels, determined with standard
analysis (see Figure 5B); this correspondence was docu-
mented by linear regression and Pearson’s correlation test
Figure 5. Hyperglycemia alters electrical properties of cardiomyocytes. A, APs recorded at 2-Hz pacing rate in cardiomyocytes isolated from
control (Ctrl) and streptozotocin (STZ)-treated female mice. B, AP properties of Ctrl myocytes (n=41; from 20 mice) and myocytes obtained from
STZ-treated female animals (n=39; from 14 mice at 12–60 days after onset of hyperglycemia) stimulated at 2 Hz are shown as median and
interquartile ranges. *P<0.05 vs Ctrl. C, Analysis and comparison of repolarization properties of APs reported in (B) using the novel algorithm.
Graph of average AP profile represents the calculated average repolarization phase of the AP for Ctrl and STZ myocytes. Corresponding error
bars, fold changes for the duration of the AP in STZ vs Ctrl cells, and statistical difference are reported in the SEM, fold change, and P-value
graphs, respectively. D, Superimposed sequential APs collected in Ctrl and STZ myocytes. E, Variability of repolarization of the AP evaluated by
SD, RSD, and STV in Ctrl and STZ myocytes reported in (B) using the novel algorithm. Graphs of SD, RSD, and STV of the AP profile represent the
calculated average variability of the repolarization phase of the AP for Ctrl and STZ myocytes. Corresponding error bars, fold changes for the
variability of the AP in STZ vs Ctrl cells, and statistical difference are reported in the SEM, fold change, and P-value graphs, respectively. AP
indicates action potential; STV, short-term variability.
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between the 2 approaches (Figure S4). Additionally, exposure
of Ctrl myocytes to 20 mmol/L of glucose, a concentration of
the sugar comparable to levels found in diabetes, had minimal
consequences on duration of AP (Figure S5), suggesting that
chronic exposure to high-glucose in vivo induces electrical
remodeling in cardiomyocytes.
To establish whether the enhanced variability of electrical
recovery in diabetic mice was associated with increased
Figure 5. Continued.
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temporal dispersion of the AP in cardiomyocytes, SD, RSD,
and short-term variability (STV)22,36,37 were calculated for 70
consecutive waveforms of the 100 APs obtained from each
cell (Figure 5D). The initial 30 excitation waveforms were
excluded from the analysis to allow the AP profile to reach a
steady-state configuration in response to commencement of
the stimulation protocol. Using the 3 parameters of variability,
repolarization was found to be more heterogeneous in
diabetic myocytes; however, dissimilarities were detected in
progressively broader repolarization ranges when RSD, STV,
and SD were employed, respectively (Figure 5E). The
enhanced temporal dispersion of the AP in diabetic cardiomy-
ocytes covered a range comprising 50.7% to 70.7% of the
whole repolarization.
In a subset of cells, APs were acquired at 2, 4, and 6 Hz to
establish whether the mechanisms of rate adaptation of AP in
Ctrl and diabetic myocytes enhanced or diminished differ-
ences between the electrical behaviors of the 2 cell types. At
faster pacing rates, prolongation of AP of diabetic myocytes
covered a broader range of repolarization (Figure 6). Similarly,
the enhanced temporal dispersion of AP of diabetic cells,
evaluated with SD and STV, involved a larger fraction of the
repolarization, which, however, was not observed with RSD
(Figure S6).
In the attempt to define the impact of the protracted
duration of AP on the electrical recovery of the intact
myocardium, local MAPs were evaluated in a small cohort of
perfused hearts in the apical and basal regions of the
Figure 6. Hyperglycemia and AP properties at different pacing rates. Analysis and comparison of repolarization properties of AP using the
novel algorithm. Control (Ctrl) myocytes (n=22; from 12 mice) and myocytes obtained from streptozotocin (STZ) -treated female mice (n=27;
from 12 mice at 18–45 days after onset of hyperglycemia) were stimulated at 2-, 4-, and 6-Hz pacing rates. Graphs of average AP profile
represent the calculated average repolarization phase of the AP for Ctrl and STZ myocytes. Corresponding error bars, fold changes for the
duration of the AP in STZ vs Ctrl cells, and statistical difference are reported in the SEM, fold change, and P-value graphs, respectively. AP
indicates action potential
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epicardial LV free wall and in the endocardium. MAP duration
at 50% repolarization was increased in the apex of hearts from
STZ mice, with respect to Ctrl, whereas electrical signals from
other anatomical regions did not differ significantly (Figure 7).
These initial results (1) link the alterations of the repolariza-
tion properties of cardiomyocyte to the defective electrical
recovery observed in vivo and (2) may be indicative of a
reduced spatial electrical gradient in diabetic hearts.
Hyperglycemia and Ionic Current Remodeling
To define the ionic basis for the observed prominent
prolongation of the early and intermediate repolarization
phase of the AP of diabetic myocytes, the density of Kv K+ and
L-type Ca2+ (ICaL) currents, operative in this range of
potentials, were tested. In agreement with previous findings
with other experimental models of diabetes,43–48 outward Kv
currents and ICaL were significantly reduced in STZ myocytes
(Figure 8A through 8D and Figure S7). These alterations may
respectively promote and oppose prolongation of AP duration.
Thus, these findings point to Kv currents as an important
determinant for the delayed repolarization phase of AP
occurring with hyperglycemia.
In the attempt to define the role of diminished outward Kv
currents on the prolongation of AP and enhanced beat-to-beat
variability observed in diabetic myocytes, outward K+ currents
in control mouse myocytes were inhibited with 4-AP
(0.1 mmol/L).32–35 This pharmacological intervention led to a
prolongation of AP comprising 95% of the whole repolarization,
Figure 7. Hyperglycemia and myocardial electri-
cal properties. A, Monophasic action potentials
obtained in the apical region of the epicardial left
ventricular (LV) free wall of hearts from control
(Ctrl) and streptozotocin (STZ) female mice. B,
Duration of monophasic action potentials at 50%
repolarization (MAPD50) in the apical (Apex) and
basal (Base) regions of the epicardial aspects and
endocaridal (Endo) aspect of the LV free wall in
hearts from Ctrl (n=10; Apex n=9; Base, n=10;
Endo, n=9) and STZ female mice (n=5; 12–30 days
after induction of diabetes; Apex, n=5; Base, n=4;
Endo, n=4). Data are reported as meanSEM.
*P<0.05 vs Ctrl; †P<0.05 within the group.
Figure 8. Hyperglycemia reduces Kv currents. A, Whole-cell
voltage-gated K+ current recorded in voltage clamp in 1 control
(Ctrl) and 1 streptozotocin (STZ) myocyte. B, I-V relation for Kv
currents and Iss for Ctrl myocytes (n=25; from 4 mice) and
myocytes obtained from STZ-treated female mice (n=27; from 10
mice at 12–30 days after onset of hyperglycemia) are shown as
meanSEM. *P<0.05 vs Ctrl. C, Whole-cell voltage-gated Ca2+
current recorded in voltage clamp at +10 mV in 1 Ctrl and 1 STZ
myocyte. D, I-V relation for ICaL for Ctrl myocytes (n=21; from 3
mice) and myocytes obtained from STZ-treated female mice (n=22;
from 4 mice at 12–19 days after induction of diabetes) are shown
as meanSEM. *P<0.05 vs Ctrl. Additional properties of ICaL are
reported in Figure S7.
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with a maximum of 5.3-fold increase in duration at 15.6% of the
repolarization (Figure 9A and 9B). Interestingly, 4-AP enhanced
repolarization variability (Figure 9C), paralleling the behavior of
diabeticmyocytes. Thus, the remodeled AP profile and temporal
dispersion of the repolarization of diabetic myocytes is partly
mimicked by exposure to 4-AP, supporting the notion that the
reduction of Kv currents in myocytes contributes to the altered
electrical properties of the diabetic heart.
Discussion
The results of the current study indicate that hyperglycemia
leads to prolongation and enhanced temporal dispersion of
the repolarization phase of AP in myocytes. These defects at
the cellular level are paralleled, in vivo, by delayed ventricular
repolarization, increased variability of electrical recovery, and
enhanced propensity to develop arrhythmias, features also
observed in diabetic patients.3–10,12,13 Densities of Kv
currents are reduced in diabetic myocytes contributing, at
least in part, to the alteration in repolarization dynamics,
modality of rate adaptation, and beat-to-beat variability of AP.
Thus, changes in Kv currents may constitute an important
mediator of electrical remodeling of the diabetic heart.
The STZ mouse model employed here is characterized by
an initial decline of diastolic function, which is commonly
found in the diabetic population.1,49–52 LV filling patterns in
STZ-treated mice are altered in the first month after onset of
hyperglycemia, whereas EF is still preserved. The electrical
characteristics of the myocardium and cardiomyocytes were
determined at this early stage of the disease to avoid the
confounding variables of the advanced myopathy,52,53 where
depressed myocyte function, cell death, and myocardial
scarring would have interfered with recognition of the
consequences of hyperglycemia per se on these physiological
parameters. By this approach, we have documented that,
together with depressed diastolic performance, reduction in
Kv K+ and L-type Ca2+ current densities, protracted electrical
Figure 9. Inhibition of Kv currents prolongs the AP and enhances beat-to-beat variability. A, Superimposed sequential APs of a nondiabetic
myocyte before and after exposure to 0.1 mmol/L of 4-AP. B, Analysis and comparison of repolarization properties of the AP using the novel
algorithm, for myocytes obtained from female mice before and after exposure to 4-AP (n=8; from 5 mice). Graph of average AP profile represents
the calculated average repolarization phase of the AP in myocytes before and after exposure to 4-AP. Corresponding error bars, fold changes for
the duration of the AP in 4-AP vs Tyrode (Tyr), and statistical difference are reported in the SEM, fold change, and P-value graphs, respectively.
C, Variability of repolarization of the AP before and after exposure of 4-AP evaluated by SD, RSD, and STV in cells reported in (B), using the novel
algorithm. Graphs of SD, RSD, and STV of AP profile represent the calculated average variability of the repolarization phase of the AP for
myocytes in Tyrode and after exposure to 4-AP. Corresponding error bars, fold changes for the variability of the AP collected in 4-AP vs Tyrode,
and statistical difference are reported in the SEM, fold change, and P-value graphs, respectively. 4-AP indicates 4-aminopyridine; AP, action
potential; STV, short-term variability.
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recovery, and enhanced temporal dispersion of repolarization
are initial functional defects of the myocardium dictated by
diabetes. The process linking reduced ionic currents with the
enhanced beat-to-beat variability of electrical recovery of the
diabetic heart may involve complex multiscale mechanisms,
from ion channels to the whole organ.22,23,54,55 The reduced
repolarizing effect of Kv currents has attenuated the repolar-
ization reserve of diabetic myocytes, potentially unmasking
fluctuations of ionic currents caused by stochastic behavior of
ion channel gating, normally concealed by K+ efflux.
Alterations of the spatial heterogeneity of ion channel
expression and AP duration have been previously reported in
rodent models of diabetes,45,56,57 which are consistent,
at least in part, with our observation of a preferential
prolongation of duration of MAPs in the epicardial/apical
region of STZ hearts. The altered regional properties of
cardiac tissue may have affected locally the refractoriness of
the myocardium, negatively interfering with electrical con-
duction and pattern of impulse propagation. Although further
experiments are warranted, these initial findings suggests that
altered spatial heterogeneity of the myocardium with diabetes
represents the basis for the alternation in the polarity of the
QRS axis observed during episodes of BVT.29,58
Reductions of the K+ channel subunit, Kv4.2, interacting
protein KChIP2, and Ca2+ channel a-1C subunit have been
proposed as molecular substrates for the decreased Kv
currents and ICaL in myocytes from rodent models of
diabetes.43,45–47,57,59 Our electrophysiological data support
Figure 9. Continued.
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the possibility that similar alterations occur in the STZ-
hyperglycemic mouse model employed here. Importantly,
reduction in the outward K+ Kv currents and prolongation of
AP duration in mammals appear to be a conserved response
to a variety of physio- and pathological conditions dictated by
an increase in workload of the myocardium, including
ischemic cardiomyopathy,60,61 hypertension,62 pressure over-
load,63 aging,20,64 and heart failure.18,65,66 Thus, the
enhanced beat-to-beat variability observed in diabetic myo-
cytes may represent a feature shared with other diseased
conditions.
A limitation of our study is related to the use of intracellular
Ca2+-buffered conditions19 in the analysis of AP characteris-
tics. This approach has abrogated the modulatory action of
Ca2+ transients on AP profile at different rates and has
prevented the manifestation of destabilizing effects of spon-
taneous Ca2+ releases on transmembrane potential. Enhanced
diastolic Ca2+ releases from the sarcoplasmic reticulum have
been previously found in myocytes obtained from diabetic
rats,67 suggesting that these spontaneous events may have
contributed to the heterogeneity of electrical recovery
observed in heart of STZ-treated mice. Although these
aspects represent important constraints to our study, we
elected to initially dissect the contribution of ionic current
remodeling on the electrical behavior of diabetic myocytes.
Thus, the reported prolongation of AP and enhanced temporal
dispersion of the repolarization phase of diabetic myocytes
may represent a conservative evaluation of the destabilizing
events occurring in diabetic cells and their implication in
occurrence of ventricular arrhythmias. Additionally, because
of the large number of tests performed, we cannot exclude
that statistical significance by chance alone may have
occurred in our analysis.
Alterations of the structural properties and intercellular
coupling of the myocardium may have occurred with
diabetes,52,68,69 weakening the electrotonic interaction
between myocytes, which acts as a mechanism of suppres-
sion of repolarization variability in situ.54,70 Thus, intervening
structural remodeling may have cooperated with reduced Kv
currents in promoting the repolarization heterogeneity found
in the diabetic heart. Also, we cannot exclude with certainty
that electrical defects observed in vivo are the consequences
of local ischemic events secondary to atherosclerosis, a
typical feature of the diabetic heart.11
The novel algorithm employed here has allowed us to
obtain detailed information on the AP profile of control and
diabetic myocytes and to define repolarization ranges in which
duration and degree of heterogeneity of AP were critically
altered by the hyperglycemic condition. Additionally, the
changes in AP profile induced by modulation of Kv currents
were outlined and the relationships with the electrical
behavior of diabetic myocytes were identified, providing proof
of concept that reduction in Kv currents is a critical
determinant of the remodeled AP shape occurring with
diabetes. The novel analytical tool reported in this study
offers a comprehensive assessment of the repolarization
dynamics of AP, which may facilitate recognition of ionic
mechanisms underlying the electrical behavior of cardiomy-
ocytes under various experimental conditions.
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